These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2392142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A structured, therapeutic approach to drug abuse.
    Alonzi J, Faigel HC.
    Pediatrics; 1972 Nov; 50(5):754-9. PubMed ID: 5084188
    [No Abstract] [Full Text] [Related]

  • 3. A differential counselor role model for the treatment of drug addicts.
    Cuskey WR, Premkumar T.
    Health Serv Rep; 1973 Nov; 88(7):663-8. PubMed ID: 4746235
    [No Abstract] [Full Text] [Related]

  • 4. Drug abuse programs: are hospitals too late and too square?
    Philips DF.
    Hospitals; 1971 Jan 16; 45(2):55-60. PubMed ID: 5123315
    [No Abstract] [Full Text] [Related]

  • 5. Treatment facilities for drug-dependent patients. Some impressions of treatment programmes in the United States and Canada.
    Jensen GR.
    Med J Aust; 1973 Apr 21; 1(16):808-12. PubMed ID: 4707801
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Forecasting the cost of drug abuse treatment coverage in private health insurance.
    McGuire TG, Shatkin BF.
    NIDA Res Monogr; 1991 Apr 21; 113():175-89. PubMed ID: 1762639
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA, Dunlap LJ, Homsi G.
    Eval Rev; 2006 Apr 21; 30(2):119-38. PubMed ID: 16492995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM, Raskin IE, Blacklow B.
    Subst Use Misuse; 2008 Apr 21; 43(5):647-79. PubMed ID: 18393082
    [Abstract] [Full Text] [Related]

  • 14. Study tracks costs of treating employees' drug problems.
    Kim H.
    Mod Healthc; 1991 Jan 21; 21(3):18. PubMed ID: 10170655
    [No Abstract] [Full Text] [Related]

  • 15. [When and how one can leave a methadone treatment program?].
    Lauzon P.
    Ann Med Interne (Paris); 1994 Nov 21; 145 Suppl 3():94-5. PubMed ID: 7880041
    [No Abstract] [Full Text] [Related]

  • 16. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.
    Arch Gen Psychiatry; 2006 Feb 21; 63(2):201-8. PubMed ID: 16461864
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.